Fintech PR
Huawei Launches the All-New CloudEngine S-Series Campus Switches and Solutions
Huawei announced a major leap in campus networking by unveiling 16 new models of CloudEngine S-series access, aggregation, and core switches. Of these releases, CloudEngine S12700E, a brand-new campus core switch, uses the Solar chipsets to increase switching capacity to a record high of 57.6 Tbit/s. The feature-rich CloudEngine S12700E is an integral part of Huawei’s end-to-end offerings that are tailored for the Wi-Fi 6 era. Additionally, with upgraded network automation and AI-powered intelligent O&M capabilities, Huawei’s CloudCampus Solution will vastly increase service rollout efficiency and help enterprises of all sizes to quickly build service-centric campus networks.
Kitty Fok, Managing Director of International Data Corporation (IDC) China, said in her keynote speech: “Digital transformation has entered a new phase. IDC predicts that by 2020, approximately 55 percent of enterprises will have ‘digital decision-making’ capabilities to achieve insights, intelligence, autonomy, and collaboration at scale.” In this kind of digital enterprise, the network will be ubiquitous and as available as the air we breathe, with management simpler than ever before.
“Campus networks, which serve as the foundation for constructing a future-proof digital platform for enterprises, are shifting their focus from data connectivity to service connectivity. As such, building intent-driven campus networks are at the top of our agenda,” said Zhao Zhipeng, President of the Campus Network Domain, Huawei’s Data Communication Product Line. “In the Wi-Fi 6 era, campus networks should take on new characteristics, including ultra-large capacity, 10-millisecond ultra-low latency, zero-configuration service rollout, and self-healing from network faults. Campus networks should also use an open architecture, facilitating smooth evolution from traditional campus networks to networks that are intelligent and simplified.”
Huawei’s Next-Generation CloudEngine S-Series Campus Switch Portfolio
The newest CloudEngine campus switches are available in 16 models: CloudEngine S5700 series (intelligent GE access switches), CloudEngine S6700 series (10GE routing aggregation switches), and CloudEngine S12700E series (innovative core switches with the highest performance in the industry). As verified by Tolly Group, CloudEngine S12700E delivers six times the switching capacity of the industry average and features the largest single-slot bandwidth, highest 100GE port density, and largest switching capacity among all comparable products. Huawei CloudEngine S-series is also the first of its kind with an optimal mix of wired and wireless convergence capabilities, a threat deception engine, and telemetry support.
Intelligent and Simplified Campus Network Centered on Service Connectivity
A service-centric network should provide not only ultra-broadband connectivity, but also offer highly automated management and intelligent O&M to accelerate service rollouts while ensuring high service quality and experience in real time.
- Automated management: With the extensive use of mobile office and cloud applications, network policy management is becoming more complex than ever. In response, Huawei CloudCampus Solution provides a one-stop network management center that automates network planning, deployment, policy, and monitoring across WLAN, LAN, and WAN through Graphical User Interfaces (GUIs), without the need for traditional Command Line Interfaces (CLIs). As a result, network management efficiency can be improved by more than 80 percent.
- Intelligent O&M: Faults can be accurately and quickly rectified only when users’ network experiences can be quantitatively measured. That’s why Huawei has upgraded its Machine Learning (ML)- and AI-powered intelligent O&M system. This new system provides quantitative experience evaluation, root cause analysis, and intelligent fault prediction, enabling network faults to be located and resolved in minutes.
- All-layer openness: In addition to such compelling network automation and intelligence features, Huawei CloudCampus Solution is designed with all-layer openness to simplify the upgrade and evolution of enterprise networks. Currently, Huawei has verified successful multi-vendor interoperability with more than 800 models of network devices from mainstream vendors worldwide; cooperated closely with over 40 partners in network management, authentication, security, and other fields; and developed joint solutions with more than 30 business partners around the world. Huawei has also built 26 Joint Validation Labs (JVLs) globally that enable quicker and smoother rollout of services through joint solution verification.
Huawei is a leading global technology and solution provider in the campus network field and provides services to customers in 150 countries and regions worldwide. According to IDC, Huawei has maintained the top spot in China’scampus switch market for four consecutive years and has ranked second in the global campus switch market for the third year in a row. Huawei campus network offerings have helped customers in education, finance, government, large enterprise, healthcare, manufacturing, and other sectors to achieve their digital transformation goals.
SOURCE Huawei
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News7 days ago
“The Hainan FTP and Me”: Looking at Hainan’s Transformations
-
Latest News5 days ago
Millions of people unite around doing good on the 18th International Good Deeds Day held yesterday worldwide
-
Latest News5 days ago
Banxso Acquires Australian ASIC License, Enhancing Its Global Trading Operations
-
Latest News3 days ago
BMO Announces Election of Board of Directors
-
Latest News5 days ago
135th Canton Fair Launches a Showcase of Innovative Products of New Collection to Lead Global Market Trends
-
Latest News4 days ago
HaloWallet Rebrands To Halo: Integrating SocialFi & AI To Revolutionize Social Influence Monetization
-
Latest News5 days ago
BII and FMO back BECIS with joint US$50 million financing facility supporting commercial and industrial renewables sector in South-East Asia
-
Latest News3 days ago
Vantage Markets Wins “Most Innovative Broker” Award from FXBT; Redefines Trader Empowerment